Sunbin Ling
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
Papers in ⓘ
-
- Metabolism, Diabetes, and Cancer 6
- Ubiquitin and proteasome pathways 6
- PI3K/AKT/mTOR signaling in cancer 5
- Oncology 20
- Cancer-related Molecular Pathways 6
- Co-authors
- Shusen Zheng (18 shared papers)Qianwei Ye (8 shared papers)Xiao Xu (20 shared papers)Tingting Feng (10 shared papers)Qiaonan Shan (9 shared papers)Haiyang Xie (8 shared papers)Xuyong Wei (8 shared papers)Kangchen Chen (3 shared papers)
- Journals
- World Journal of Surgical Oncology (2 papers)European Journal of Surgical Oncology (2 papers)Cell Death and Disease (2 papers)Advanced Science (2 papers)International Journal of Surgery (1 paper)
- Partner nations
- ChinaUnited StatesMadagascar
In The Last Decade
Sunbin Ling
46 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 97
- Hepatology 232
- Cancer Research 402
- Oncology 533
- Molecular Biology 790
- Transplantation 22
Countries citing papers authored by Sunbin Ling
This map shows the geographic impact of Sunbin Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sunbin Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sunbin Ling more than expected).
Fields of papers citing papers by Sunbin Ling
This network shows the impact of papers produced by Sunbin Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sunbin Ling. The network helps show where Sunbin Ling may publish in the future.
Co-authors
The 25 scholars most cited alongside Sunbin Ling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 287 | |
| 2 | 2020 | 155 | |
| 3 | 2017 | 84 | |
| 4 | 2016 | 79 | |
| 5 | 2021 | 76 | |
| 6 | 2017 | 61 | |
| 7 | 2014 | 55 | |
| 8 | 2017 | 51 | |
| 9 | 2021 | 49 | |
| 10 | 2019 | 45 | |
| 11 | 2014 | 44 | |
| 12 | 2021 | 42 | |
| 13 | 2022 | 30 | |
| 14 | 2019 | 27 | |
| 15 | 2014 | 27 | |
| 16 | 2014 | 26 | |
| 17 | 2014 | 22 | |
| 18 | 2014 | 19 | |
| 19 | Knock-down of USP22 by small interfering RNA interference inhibits HepG2 cell proliferation and induces cell cycle arrest. | 2012 | 19 |
| 20 | 2020 | 18 |
About Sunbin Ling
Sunbin Ling is a scholar working on Molecular Biology, Oncology, Surgery, Epidemiology and Hepatology, having authored 50 papers that have together received 1.4k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Cancer-related Molecular Pathways (6 papers), Metabolism, Diabetes, and Cancer (6 papers), Ubiquitin and proteasome pathways (6 papers), Organ Transplantation Techniques and Outcomes (6 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers) and Cancer, Hypoxia, and Metabolism (5 papers). The work is most often cited by research in Hepatology (232 citations), Cancer Research (402 citations), Oncology (533 citations), Molecular Biology (790 citations) and Transplantation (22 citations). Sunbin Ling has collaborated with scholars based in China, United States and Madagascar. Frequent co-authors include Shusen Zheng, Qianwei Ye, Xiao Xu, Tingting Feng, Qiaonan Shan, Haiyang Xie, Xuyong Wei, Kangchen Chen, Penghong Song and Shengjun Xu. Their work appears in journals such as World Journal of Surgical Oncology, European Journal of Surgical Oncology, Cell Death and Disease, Advanced Science and International Journal of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.